Toxys Awarded £1M for phase 2 of CrossDART CRACK IT Challenge
To address the need for reliable cell based in vitro assays that predict the teratogenicity of new drug candidates in both human and other animal species, Toxys have participated in CrossDART CRACK IT Challenge, developing and characterizing muti-species assays. After successfully completing phase 1 of...
ERC Proof of Concept Grant for Developing ReproTox
Professor Susana Chuva de Sousa Lopes at the Leiden University Medical Center partnered with Toxys and received a European Research Council Proof of Concept grant for developing ReproTox. This novel human stem cell-based assay will enable screening chemicals and environmental factors for their potential toxic...
Create2Solve Funded Consortium Annual Progress Meeting
Toxys is one of the five partners in the ‘Better in vitro dosing’ consortium, funded by ZonMw’s Create2Solve subsidy program. The aim of the project is to develop alternative dosing technologies for in vitro assays to better reflect human exposure. These novel dosing approaches should...
Toxys Awarded Phase 1 Project in CRACK IT Challenge
CRACK IT is a challenge-led competition that funds collaborations between industry, academics and SMEs to solve business and scientific Challenges which will deliver 3Rs benefits, either by improving business processes or developing a commercial product. Depending on the Challenge, contracts of up to £1M for...
Toxys and Omnigen receive MIT grant to develop Toxplot software for animal-free chemical safety testing.
4 January 2018 - Toxys and Omnigen have received a MIT grant for the development and extension of the ToxPlot software. With this grant, the ToxPlot analysis tool will be further developed to allow quantitative and hypothesis-free toxicity profiling of novel chemicals. Currently, ToxPlot is...
Toxys has been awarded Innovation Credit to further develop ReproTracker
Leiden 20 September 2017 - Today Toxys was awarded an Innovation Credit from RVO to accelerate the develop of the ReproTracker assay. ReproTracker® is a state-of-the-art in vitro reporter assay to rapidly identify compounds that disturb stem cell differentiation and early embryonic development. Testing for...
Toxys awarded € 50.000 by EIT Health to develop ReproTracker – an in vitro assay for reproductive toxicity
21 September 2016 - Today Toxys was awarded a €50.000 grant for a head-start project to further develop the ReproTracker. Toxys is dedicated to develop innovative in vitro toxicity assays that provide insight into the mechanisms of toxicity. Toxys' lead product ToxTracker is a genotoxicity...
